Advertisement

Procarta Biosystems Company Profile

04:20 EDT 22nd May 2013 | BioPortfolio

Procarta Biosystems is developing a new class of DNA-based therapeuticals, snare™ antibacterials, capable of combating drug-resistant bacterial infections. snare™ antibacterials act on novel genomic targets by capturing key regulatory proteins to block essential bacterial genes and defeat infection.

Procarta is creating an extensive pipeline to tackle some of the most challenging bacterial infections in the clinic. The WHO is predicting a forthcoming 'disaster due to the rapid, unchecked increase in antimicrobial resistance' largely as a consequence of the paucity of new classes of antibacterials in development.

The proprietary technology platform underlying snare™ is highly adaptable and can be tuned to meet both current and future clinical needs. As such, snare™ antibacterials are being developed as agents of first resort to treat today's drug-resistant superbugs.

Location

Norwich Bio-Incubator
Norwich Research Park, Colney Lane
Norwich
Norfolk
NR4 7UH
UK

Contact

Phone: +44 (0) 1603 450960
Fax: +44 (0)1603 450778
Email: info@procartabio.com


News Articles [ 139 Associated News Articles listed on BioPortfolio]

Procarta Biosystems gains further funding and IP protection

Poised to expand research into its ‘snare antibacterials

Procarta, University of East Anglia Medical School deal

FIGHT BACK AGAINST MRSA TO BE STARTED WITH A SNIFF - Novel Procarta technology to disable killer bacteria in a nasal spray

7th March 2013: An innovative anti-bacterial spray that will kill just MRSA is being developed by Norwich Research Park scientists. The spray, which can be used in the nose to decolonise patients...

Genera Biosystems: Diagnostics Come of Age

In early 2008 Genera Biosystems was floated on the ASX and, despite the current economic environment, the CEO, Allen Bollands is feeling positive about the company’s future. He predicts that a ‘go...

AyoxxA Biosystems closes 2.6M Euro Series A financing round

AyoxxA Biosystems, an international biotechnology company, today announces it has closed a 2.6 million Euro Series A financing round. The round was led by Wellington Partners Venture Capital and inclu...

Tecan and TAP Biosystems to automate RAFT™ 3D cell culturing on the Freedom EVO®

Tecan and TAP Biosystems have announced a co-marketing agreement...

Rapid Micro Biosystems Announces ISO 9001:2008 Certification

BEDFORD, MA -- (Marketwired) -- 04/16/13 -- Rapid Micro Biosystems, the provider of rapid, automated, non-destructive detection and enumeration technologies in microbiology, today announced it has be...

Leica Biosystems Launches the EXPERIENCELAB Tour

Leica Biosystems announced the launch of the EXPERIENCELAB tour, a mobile demonstration lab that showcases Leica's full line of anatomical pathology solutions. Customers will be able to visit the EXPE...

Drugs and Medications [0 Results]

None

PubMed Articles [ 44 Associated PubMed Articles listed on BioPortfolio]

Some remarks on predicting multi-label attributes in molecular biosystems.

Many molecular biosystems and biomedical systems belong to the multi-label systems in which each of their constituent molecules possesses one or more than one function or feature, and hence needs one...

Front cover.

Front cover.

Contents list.

Contents list.

Clinical Trials [0 Results]

None

Companies [ 91 Associated Companies listed on BioPortfolio]

Procarta Biosystems

Procarta Biosystems is developing a new class of DNA-based therapeuticals, snare™ antibacterials, capable of combating drug-resistant bacterial infections. snare™ antibacterials act on n...

Silicon Biosystems, Inc.

Silicon Biosystems, Inc. was formed in October of 2010 as a wholly owned subsidiary of Silicon Biosystems, S.p.A. based in Bologna, Italy. The Company manufactures and sells the D...

Kapa Biosystems

Kapa Biosystems is a next-generation life science reagents supplier that employs high-throughput molecular evolution to optimize enzymes for DNA amplification, next-generation DNA...

Silicon Biosystems

Silicon Biosystems, S.p.A. is based in Bologna, Italy and has developed a set of proprietary solutions called lab-on-a-chip technologies, targeted at miniaturized cell-biology tes...

Stedim Biosystems S.A.

Stedim Biosystems has more than twenty five years experience in the design and manufacture of flexible plastic containers for the world's largest healthcare and pharmaceutical companies. We have pio...

More Information about "Procarta Biosystems" on BioPortfolio

We have published hundreds of Procarta Biosystems news stories on BioPortfolio along with dozens of Procarta Biosystems Clinical Trials and PubMed Articles about Procarta Biosystems for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Procarta Biosystems Companies in our database. You can also find out about relevant Procarta Biosystems Drugs and Medications on this site too.

Search BioPortfolio:
Advertisement

Corporate Database Quicklinks



Searches Linking to this Company Record

Advertisement